URCC 10055 Closing Accrual on April 28th 2017 PDF Print E-mail
Written by Jim Delmonico   
Friday, 06 January 2017 15:18

URCC10055: Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment, and at Six Month Follow-Up  will be closing to accrual Friday, April 28.  We have reached 99% accrual, and at the current rate of enrollment, we will hit our target accrual by the end of April.

Please note the following:

  • Both chemo patients and their matched controls MUST BE registered by April 28.
  • Continue to collect data per protocol on any participants currently on study and on those enrolled by April 28 until they go off study.
  • Registration for the Assessment 4 and 5 Sub-study is NOT closing.  Continue to register participants who consent to the substudy when they are eligible.

As usual, please direct any protocol questions to Libby Nagalski.

Last Updated on Wednesday, 11 January 2017 09:07